๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Monoclonal Antibodies MA54 and MA61 as Potential Reagents in the Prognosis of Patients with Ovarian Cancer

โœ Scribed by Hiroshi Kobayashi; Hidekazu Ohi; Motoi Sugimura; Hiromitsu Shinohara; Toshihiko Terao

Book ID
115615811
Publisher
Elsevier Science
Year
1993
Tongue
English
Weight
271 KB
Volume
49
Category
Article
ISSN
0090-8258

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Specificity of a Tumor Marker (CA54/61)
Specificity of a Tumor Marker (CA54/61) and Its Individual Epitopes Recognized by Monoclonal Antibodies, MA54 and MA61, in Human Tumor Patients
โœ Dr. Hiroshi Mochizuki; Kimiko Nagoya; Tadakazu Yamauchi; Yoshimi Takao; Hideyuki ๐Ÿ“‚ Article ๐Ÿ“… 1992 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 615 KB

The specificityofa tumor marker (CA54/61) and its individual epitopes (CA54 and CA61) recognized by monoclonal antibodies (MA54 and MA6l) and expressed by the same tumor marker were studied. Serum levels of CA54 and CA61 were compared with that of CA54l 61. In lung adenocarcinoma and ovarian carcino

The measurement of leukocyte subsets in
The measurement of leukocyte subsets in the peripheral blood of cancer patients with solid tumors using monoclonal antibody reagents
โœ Harris, Jules E. ;Deboer, Kathie P. ;Vahey, Anne L. ;Braun, Donald P. ๐Ÿ“‚ Article ๐Ÿ“… 1982 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 582 KB

## Abstract Monocyte and lymphocyte subsets were quantitated in the peripheral blood of normal subjects and patients with solid tumors using the monoclonal antibody reagents OKM1, BRL63D3, OKT3, OKT4, and OKT8. Percentages and numbers of cells reacting with monoclonal reagents were analyzed by indi

Immunoscintigraphy with 131I-labelled mo
Immunoscintigraphy with 131I-labelled monoclonal antibodies HMFG2 and HMFG1 F(ab')2 versus abdominal CT scan in the detection of residual disease in ovarian cancer patients
โœ D. Pectasides; K. Pateniotis; L. Tzimis; X. Trapalli; P. Natsis; P. Arapantoni; ๐Ÿ“‚ Article ๐Ÿ“… 1988 ๐Ÿ› John Wiley and Sons ๐ŸŒ French โš– 514 KB

3'I-labelled HMFGl or HMFGl F(ab')2 monoclonal antibody (MAb) was administered intraperitoneally to I S patients with epithelial ovarian cancer who had completed chemotherapy and were in complete or good partial remission. Each patient received 2-3 mCi. Patients were scanned immediately after and un